Pharmaceutical and Research Fraud with Global Implications – A Case Report
Countless individuals and patients at risk of Alzheimer's have been deprived of their health and recovery opportunities, as has now been proven beyond doubt—and more importantly, acknowledged—thanks to AI-supported data analysis. This is a veritable crime of the century, appearing at first to center around a single individual. However, the pharmaceutical industry, government institutions, and numerous pharma-funded scientists have assisted him in setting a mind-destroying, life-threatening profit machine in motion and keeping it running; at least, if even more far-reaching motives were not at play. But let me start elsewhere.
Dear reader,
This article was available exclusively to my paid subscribers for just over two weeks before being released to all readers, as is customary on my substack. The information is too important to limit, but as a gesture of thanks, I am giving my paid subscribers early access.
Michael Nehls
The Alzheimer’s Industry: A Profitable Business Model
In 2016, I published the peer-reviewed article Unified Theory of Alzheimer's Diseases (UTAD) in the Journal of Molecular Psychiatry. The facts presented in this article have serious implications for the prevention and treatment of Alzheimer’s disease: Alzheimer’s is a preventable disease and still reversible in the early stages (see here). Since my theory of Alzheimer’s development as a multi-causal process, calling for a systemic approach to prevention, is based on thousands of studies and cannot be refuted on content alone, pharma-affiliated scientists and journalists have consistently attacked me on a personal level to discredit my work indirectly. From the perspective of the profit-driven pharmaceutical industry, it simply could not be allowed to exist. With this publication, I have done far more to end the Alzheimer’s pandemic than the entire pharmaceutical industry combined. However, by identifying a species-appropriate lifestyle as the actual foundation for Alzheimer’s prevention and early-stage therapy, I also removed the justification for a highly lucrative business sector.
But instead of recommending and promoting this natural approach to Alzheimer’s prevention and early-stage therapy, in 2016 the U.S. Congress unleashed a flood of new funding for pharmaceutical-oriented Alzheimer’s research. The U.S. National Institute on Aging (NIA) appointed brain researcher Eliezer Masliah as Director of the Neuroscience Department, whose budget of $2.6 billion in the last fiscal year of 2023, according to a report in the renowned scientific journal Science on September 26, 2024 (see here), dwarfed the rest of the NIA’s research budget.
Scientific Fraud in Alzheimer’s Research
However, since Alzheimer’s is a deficiency disease, as my UTAD article clearly demonstrates, and since no drug can, of course, correct a disease-causing deficiency, Masliah had only one option to use his enormous research budget in a pharma-friendly way: fraud!
As the global intellectual leader of pharma-driven Alzheimer’s research, Masliah, as reported by Science in the cited article, has falsified hundreds of scientific studies, including supposedly successful studies on the latest Alzheimer’s drugs (see here). The falsified work primarily focused on vaccines, much like nearly all recent 'discoveries' aimed at combating diseases, framing vaccines as a kind of universal cure.
In this case, the target is a brain protein called β-amyloid. The glaring issue with this approach is that β-amyloid is essential for memory function. In my book The Alzheimer’s Lie (not yet published in English), I described this approach as life-threatening science fiction. As early as 2022, Science had to report that the therapeutic β-amyloid approach was based on a fabricated lie. However, this did not stop anyone from pursuing it scientifically and marketing it profitably with novel passive vaccines—necessitating, as we now see, even further lies. In this context, 'passive' refers to the administration of antibodies against β-amyloid, which, among other things, leads to encephalitis.
Deception and Suffering: The Dangerous Consequences for Everyone
Who suffers from this? All of us! Not only are patients treated incorrectly; as long as these lies create false hope for effective future medications that will never materialize, the rest of the population is discouraged from taking responsibility for their mental health early enough. After all, a false impression is created that we don’t have to act when pharmaceutical 'preachers' convince us that only age and our bad genes are to blame for Alzheimer’s. The fatal consequence of this misconception is that only suicide or, at best, the pharmaceutical industry can spare us from Alzheimer’s.
If you think this is polemic, I recommend reading an article from the Süddeutsche Zeitung (translated from German) on December 13, 2015. According to their research, “of course [...] there is a means of preventing Alzheimer’s,” and it comes from America’s most famous Alzheimer’s researcher and one of the leading industry consultants, neurologist Dennis Selkoe; according to him, it works “almost 100 percent”:
“‘If you want to avoid getting Alzheimer’s, there’s only one rule to follow,’ said Selkoe: ‘Choose the right parents and die early.’”
But that was not enough. They also felt compelled to attack me personally in the same article and for the reasons mentioned above—mind you, without first asking me for a comment, which would have been the professional thing to do:
“Of course, you can also dismiss all this Alzheimer’s talk and the horror scenarios as one big conspiracy—naturally by the pharmaceutical industry, which, as usual, is only thinking about profits. And if you market this wonderful theory—without thinking about profit, of course—aggressively enough, you can even make it onto the Spiegel bestseller list [the German equivalent of the New York Times bestseller list]. Just like Michael Nehls, who wrote The Alzheimer’s Lie and Alzheimer’s Is Curable. You just have to eat healthily, get enough sleep, and avoid stress—and all the Alzheimer’s researchers in the world will be out of a job.
It’s true that a healthy lifestyle is, in general, better than an unhealthy one. But Christian Haass [perhaps Germany’s most prominent β-amyloid researcher], who leads the Center for Stroke and Dementia Research in Großhadern, struggles to keep his composure in the face of such theories: 'One can only hope that Mr. Nehls never has to face an incurable Alzheimer’s patient in his own family, or even falls ill himself. Then he, too, would wish for an effective drug.'“
Affordable Lithium vs. Ineffective, Expensive, and Harmful Aducanumab and Co.
Who benefits from this agitation? Who benefits from the false β-amyloid narrative? The pharmaceutical industry and the researchers it funds worldwide!
A study on the “Comparative Efficacy of Lithium and Aducanumab [antibodies against β-amyloid] in Cognitive Decline in Patients with Mild Cognitive Impairment [MCI] or Alzheimer’s Disease [AD]” (see here) showed that the essential but commonly deficient trace element lithium is effective even at low doses, while the pharmaceutical agent actually accelerates the disease process. However, according to the article, “in 2021, the U.S. Food and Drug Administration granted accelerated approval [not for lithium, but rather] for Aducanumab.”
We’re also familiar with the accelerated approval of life-threatening drugs from the COVID-19 genetic interventions disguised as vaccinations. “The cost of Aducanumab is high,” as the article notes, “amounting to about $28,000 per person per year. By contrast, lithium is much cheaper at $40 per year and has reportedly been effective in treating cognitive decline, observed in patients with both mild cognitive impairment and Alzheimer’s disease.”
I highlighted in my UTAD article that lithium is effective against Alzheimer’s, presenting both the scientific rationale and citing successful studies. The same applies to my book Alzheimer’s Is Curable – A Timely Return to a Healthy Life (not yet published in English). This is therefore neither surprising nor new. The fact that lithium not only outperforms Aducanumab but also all marketed 'vaccines' against β-amyloid was confirmed in an analysis published in February 2024 (see here).
Similarly, it’s no surprise that the more profitable treatment results in exactly what it aims to prevent, as stated in the title of a scientific review article from 2023: “Accelerated Brain Volume Loss with Anti-β-Amyloid Drugs” (see here).
In contrast, Alzheimer’s therapy based on UTAD concepts has been successful, as I describe in my books on this topic as well as in this article (English). Because one thing should be clear: if the Alzheimer’s disease process can demonstrably be halted or even reversed in the early stages through a natural, brain-friendly lifestyle, then this approach should also offer a natural defense against Alzheimer’s. Conversely, it should come as no surprise to any thoughtful person how dangerous unnatural vaccinations can be for health. In his book A Guide to Health, Mahatma Gandhi eloquently protested over a hundred years ago against this measure, which is, from an unbiased medical perspective, more than just questionable:
Vaccination is a barbarous practice, and it is one of the most fatal of all the delusions current in our time, not to be found even among the so-called savage races of the world. Its supporters are not content with its adoption by those who have no objection to it, but seek to impose it with the aid of penal laws and rigorous punishments on all people alike.
Mahatma Gandhi
As we can see today, the issue of compulsory vaccination is closely linked to the question of freedom and self-determination more than almost any other topic—so it’s no wonder that a freedom activist also felt compelled to comment on this (primarily harmful) medical intervention. In any case, lies, censorship, and threats of punishment will not be enough to suppress human thought, even today. In the end, as is bound to happen again in this case, the truth will always prevail.